EMA Committee Urges Approval of Humira Biosimilar Imraldi to Treat IBDs
News
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion regarding on marketing authorization for Imraldi (adalimumab), a biosimilar candidate referencing Humira. The EMA ... Read more